Go Pro

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$50.53 -1.01 (-1.96%)
Closing price 07/17/2026 03:59 PM Eastern
Extended Trading
$50.60 +0.07 (+0.14%)
As of 07/17/2026 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

INSP vs. BLCO, LIVN, MMED, NVST, and IRTC

Should you buy Inspire Medical Systems stock or one of its competitors? MarketBeat compares Inspire Medical Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Inspire Medical Systems include Bausch + Lomb (BLCO), LivaNova (LIVN), MiniMed Group (MMED), Envista (NVST), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.

How does Inspire Medical Systems compare to Bausch + Lomb?

Bausch + Lomb (NYSE:BLCO) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

Inspire Medical Systems has a net margin of 14.33% compared to Bausch + Lomb's net margin of -4.21%. Inspire Medical Systems' return on equity of 10.35% beat Bausch + Lomb's return on equity.

Company Net Margins Return on Equity Return on Assets
Bausch + Lomb-4.21% 3.60% 1.69%
Inspire Medical Systems 14.33%10.35%8.81%

11.1% of Bausch + Lomb shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 1.5% of Bausch + Lomb shares are held by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Bausch + Lomb has a beta of 0.56, indicating that its stock price is 44% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.71, indicating that its stock price is 29% less volatile than the broader market.

In the previous week, Inspire Medical Systems had 4 more articles in the media than Bausch + Lomb. MarketBeat recorded 5 mentions for Inspire Medical Systems and 1 mentions for Bausch + Lomb. Inspire Medical Systems' average media sentiment score of 1.12 beat Bausch + Lomb's score of 0.58 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Bausch + Lomb
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has lower revenue, but higher earnings than Bausch + Lomb. Bausch + Lomb is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bausch + Lomb$5.21B1.11-$360M-$0.62N/A
Inspire Medical Systems$911.98M1.60$145.42M$4.4911.25

Bausch + Lomb presently has a consensus target price of $18.00, indicating a potential upside of 10.70%. Inspire Medical Systems has a consensus target price of $81.26, indicating a potential upside of 60.83%. Given Inspire Medical Systems' higher possible upside, analysts clearly believe Inspire Medical Systems is more favorable than Bausch + Lomb.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bausch + Lomb
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.21
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19

Summary

Inspire Medical Systems beats Bausch + Lomb on 14 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to LivaNova?

Inspire Medical Systems (NYSE:INSP) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

Inspire Medical Systems has higher earnings, but lower revenue than LivaNova. Inspire Medical Systems is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M1.60$145.42M$4.4911.25
LivaNova$1.39B3.19-$242.47M$1.9541.38

Inspire Medical Systems presently has a consensus price target of $81.26, suggesting a potential upside of 60.83%. LivaNova has a consensus price target of $81.38, suggesting a potential upside of 0.84%. Given Inspire Medical Systems' higher probable upside, equities analysts clearly believe Inspire Medical Systems is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19
LivaNova
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.60

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 0.4% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Inspire Medical Systems has a beta of 0.71, meaning that its share price is 29% less volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market.

Inspire Medical Systems has a net margin of 14.33% compared to LivaNova's net margin of 7.48%. LivaNova's return on equity of 16.48% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems14.33% 10.35% 8.81%
LivaNova 7.48%16.48%7.59%

In the previous week, Inspire Medical Systems had 3 more articles in the media than LivaNova. MarketBeat recorded 5 mentions for Inspire Medical Systems and 2 mentions for LivaNova. Inspire Medical Systems' average media sentiment score of 1.12 beat LivaNova's score of 0.72 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LivaNova
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Inspire Medical Systems beats LivaNova on 9 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to MiniMed Group?

Inspire Medical Systems (NYSE:INSP) and MiniMed Group (NASDAQ:MMED) are both medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 19.7% of MiniMed Group shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 2.2% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Inspire Medical Systems currently has a consensus target price of $81.26, suggesting a potential upside of 60.83%. MiniMed Group has a consensus target price of $21.33, suggesting a potential upside of 26.01%. Given Inspire Medical Systems' higher possible upside, equities analysts plainly believe Inspire Medical Systems is more favorable than MiniMed Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19
MiniMed Group
1 Sell rating(s)
2 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.73

Inspire Medical Systems has a net margin of 14.33% compared to MiniMed Group's net margin of 0.00%. Inspire Medical Systems' return on equity of 10.35% beat MiniMed Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems14.33% 10.35% 8.81%
MiniMed Group N/A N/A N/A

In the previous week, MiniMed Group had 3 more articles in the media than Inspire Medical Systems. MarketBeat recorded 8 mentions for MiniMed Group and 5 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.12 beat MiniMed Group's score of 0.13 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MiniMed Group
1 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Inspire Medical Systems has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M1.60$145.42M$4.4911.25
MiniMed Group$3.10B1.53-$190.97M-$0.68N/A

Summary

Inspire Medical Systems beats MiniMed Group on 12 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to Envista?

Inspire Medical Systems (NYSE:INSP) and Envista (NYSE:NVST) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

Inspire Medical Systems has a net margin of 14.33% compared to Envista's net margin of 2.41%. Inspire Medical Systems' return on equity of 10.35% beat Envista's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems14.33% 10.35% 8.81%
Envista 2.41%7.11%3.91%

In the previous week, Inspire Medical Systems had 4 more articles in the media than Envista. MarketBeat recorded 5 mentions for Inspire Medical Systems and 1 mentions for Envista. Inspire Medical Systems' average media sentiment score of 1.12 beat Envista's score of 1.02 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Envista
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has higher earnings, but lower revenue than Envista. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M1.60$145.42M$4.4911.25
Envista$2.81B1.55$47M$0.4165.18

Inspire Medical Systems presently has a consensus price target of $81.26, suggesting a potential upside of 60.83%. Envista has a consensus price target of $28.54, suggesting a potential upside of 6.79%. Given Inspire Medical Systems' higher probable upside, equities research analysts plainly believe Inspire Medical Systems is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19
Envista
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.38

Inspire Medical Systems has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

94.9% of Inspire Medical Systems shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by company insiders. Comparatively, 1.0% of Envista shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Inspire Medical Systems beats Envista on 12 of the 17 factors compared between the two stocks.

How does Inspire Medical Systems compare to iRhythm Technologies?

iRhythm Technologies (NASDAQ:IRTC) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

Inspire Medical Systems has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
iRhythm Technologies$747.14M4.88-$44.55M-$0.86N/A
Inspire Medical Systems$911.98M1.60$145.42M$4.4911.25

iRhythm Technologies presently has a consensus target price of $186.62, suggesting a potential upside of 68.30%. Inspire Medical Systems has a consensus target price of $81.26, suggesting a potential upside of 60.83%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iRhythm Technologies
1 Sell rating(s)
1 Hold rating(s)
12 Buy rating(s)
2 Strong Buy rating(s)
2.94
Inspire Medical Systems
2 Sell rating(s)
14 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.19

Inspire Medical Systems has a net margin of 14.33% compared to iRhythm Technologies' net margin of -3.53%. Inspire Medical Systems' return on equity of 10.35% beat iRhythm Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
iRhythm Technologies-3.53% -10.26% -1.39%
Inspire Medical Systems 14.33%10.35%8.81%

94.9% of Inspire Medical Systems shares are held by institutional investors. 1.0% of iRhythm Technologies shares are held by company insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, iRhythm Technologies had 5 more articles in the media than Inspire Medical Systems. MarketBeat recorded 10 mentions for iRhythm Technologies and 5 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.12 beat iRhythm Technologies' score of 0.10 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
iRhythm Technologies
2 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Inspire Medical Systems
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

iRhythm Technologies has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market.

Summary

Inspire Medical Systems beats iRhythm Technologies on 10 of the 17 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsMEDICAL INFO SYS IndustryMedical SectorNYSE Exchange
Market Cap$1.46B$1.79B$6.87B$23.38B
Dividend YieldN/AN/A2.67%4.16%
P/E Ratio11.2576.3127.2530.95
Price / Sales1.6029.34517.85171.69
Price / Cash17.6727.2952.9931.95
Price / Book1.885.4410.694.76
Net Income$145.42M-$54.76M$3.59B$1.07B
7 Day Performance-2.89%-2.18%-2.20%-0.01%
1 Month Performance18.44%1.57%1.63%1.08%
1 Year Performance-60.20%-1.83%25.64%16.70%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
4.4676 of 5 stars
$50.53
-2.0%
$81.26
+60.8%
-60.2%$1.46B$911.98M11.251,333
BLCO
Bausch + Lomb
3.5275 of 5 stars
$16.25
+0.1%
$18.00
+10.8%
+17.0%$5.80B$5.10BN/A13,000
LIVN
LivaNova
1.8862 of 5 stars
$82.98
+0.5%
$80.75
-2.7%
+92.2%$4.54B$1.39B42.553,300
MMED
MiniMed Group
2.5814 of 5 stars
$16.10
+5.3%
$21.33
+32.5%
N/A$4.52B$3.10BN/A8,000
NVST
Envista
2.5359 of 5 stars
$26.23
+1.2%
$28.54
+8.8%
+37.3%$4.22B$2.72B63.9712,000

Related Companies and Tools


This page (NYSE:INSP) was last updated on 7/19/2026 by MarketBeat.com Staff.
From Our Partners